DUBLIN,Nov. 5, 2014/PRNewswire/ –Actavis plc, a respected global specialty pharmaceutical company, today announced that Chief Financial OfficerR. Todd Joycewill retire fromActavisin early 2015 sildenafil accord . To ensure a smooth transition, the ongoing company said Mr. Joyce will continue as the Organization's CFO until a successor is named.Actavishas engaged a respected executive search firm to identify a successor. Although Todd and I have only worked collectively formally sinceJuly 1, february through the July close we collaborated in the planning procedure from the announcement of the Forest acquisition last, and we continue steadily to work carefully today as we come together as a built-in company generating strong economic performance, saidBrent Saunders,President and ActavisCEO.
Actavis launches Terbinafine hydrochloride tablets in the U.S.S. Distribution of the product will commence immediately. Terbinafine hydrochloride tablets, the generic exact carbon copy of Novartis’ Lamisil tablets, will be available in 250 mg strength. Terbinafine hydrochloride tablets are indicated for the treatment of fungal attacks of the fingernail and toenail. Annual product sales of terbinafine hydrochloride tablets in the U.S. Were approximately US$687 million for the twelve months ending March 2007 relating to IMS Wellness data.